1. Home
  2. CGTX vs BRLT Comparison

CGTX vs BRLT Comparison

Compare CGTX & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • BRLT
  • Stock Information
  • Founded
  • CGTX 2007
  • BRLT 2005
  • Country
  • CGTX United States
  • BRLT United States
  • Employees
  • CGTX N/A
  • BRLT N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • BRLT Consumer Specialties
  • Sector
  • CGTX Health Care
  • BRLT Consumer Discretionary
  • Exchange
  • CGTX Nasdaq
  • BRLT Nasdaq
  • Market Cap
  • CGTX 20.5M
  • BRLT 21.8M
  • IPO Year
  • CGTX 2021
  • BRLT 2021
  • Fundamental
  • Price
  • CGTX $0.26
  • BRLT $1.35
  • Analyst Decision
  • CGTX Strong Buy
  • BRLT Hold
  • Analyst Count
  • CGTX 5
  • BRLT 3
  • Target Price
  • CGTX $5.63
  • BRLT $1.80
  • AVG Volume (30 Days)
  • CGTX 1.8M
  • BRLT 55.6K
  • Earning Date
  • CGTX 08-07-2025
  • BRLT 08-07-2025
  • Dividend Yield
  • CGTX N/A
  • BRLT N/A
  • EPS Growth
  • CGTX N/A
  • BRLT N/A
  • EPS
  • CGTX N/A
  • BRLT N/A
  • Revenue
  • CGTX N/A
  • BRLT $418,708,000.00
  • Revenue This Year
  • CGTX N/A
  • BRLT $3.79
  • Revenue Next Year
  • CGTX N/A
  • BRLT $3.85
  • P/E Ratio
  • CGTX N/A
  • BRLT N/A
  • Revenue Growth
  • CGTX N/A
  • BRLT N/A
  • 52 Week Low
  • CGTX $0.22
  • BRLT $1.25
  • 52 Week High
  • CGTX $2.54
  • BRLT $2.68
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 37.68
  • BRLT 41.47
  • Support Level
  • CGTX $0.29
  • BRLT $1.32
  • Resistance Level
  • CGTX $0.32
  • BRLT $1.46
  • Average True Range (ATR)
  • CGTX 0.03
  • BRLT 0.05
  • MACD
  • CGTX 0.00
  • BRLT -0.00
  • Stochastic Oscillator
  • CGTX 12.50
  • BRLT 17.86

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About BRLT Brilliant Earth Group Inc.

Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.

Share on Social Networks: